placebokontrollierte untersuchung zur wirkung von nikotinsaure auf die dyslipidamie bei metabolischem syndrom und das arterioskleroserisiko (placebo controlled investigation of efficacy of nicotine acid [niacin] on dyslipidaemia in patients with metabolic syndrome and the risk of atherosclerosis).
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2013
At a glance
- Drugs Niacin (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Sponsors GWT-TUD GmbH
- 10 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2009 Additinal lead trial centre added as reported by Clinicaltrials.gov
- 07 May 2008 New trial record.